Results 271 to 280 of about 40,178 (286)

Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database

Journal of Clinical Pharmacy and Therapeutics, 2016
Unax Lertxundi, C Aguirre
exaly  

Bullous pemphigoid

Journal of the American Academy of Dermatology, 1982
openaire   +2 more sources

Autoimmune Bullous Dermatoses: A Review

Annals of the New York Academy of Sciences, 2009
Paulo Filipe, Patrícia Patrício
exaly  

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga, Marie Aleth Richard, René Valero   +2 more
exaly  

Mortality of patients with bullous pemphigoid in Korea

Journal of the American Academy of Dermatology, 2014
Ji Hye Lee, Soo-Chan Kim
exaly  

The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen

Archives of Dermatological Research, 1996
Takashi Hashimoto, Masayuki Amagai
exaly  

Bullous dermatosis. Bullous pemphigoid.

The Netherlands journal of medicine, 2009
S, Vano-Galvan, R, Carrillo, C, Moreno, P, Jaen   +3 more
openaire   +1 more source

IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis

British Journal of Dermatology, 2000
H F Merk, T Hunziker
exaly  

Bullous pemphigoid induced by vildagliptin: a report of three cases

Fundamental and Clinical Pharmacology, 2015
Johana Béné, Sophie Gautier, Dominique Hillaire-Buys   +2 more
exaly  

Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study

British Journal of Dermatology, 2009
T Hunziker
exaly